Boston Area Diabetes and Endocrinology Research Center (BADERC)
Boston Area Diabetes and Endocrinology Research Center (BADERC)
批准号:
10586200
负责人:
ALEXANDER A SOUKAS
金额:
$109.07万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-15 至 2028-04-30
关键词:
Academic Medical CentersAcademic supportAddressAreaAutoimmunityBioinformaticsBlood VesselsBostonCellular biologyClinicalClinical InvestigatorCollaborationsCommunicationCommunitiesDana-Farber Cancer InstituteDevelopmentDiabetes MellitusDirect CostsEducationEndocrinologyEnsureEtiologyFosteringGeneral HospitalsGenesGenomicsGraft RejectionGrantHospitalsImageImmunologicsInstitutionInsulinInsulin ResistanceInternationalIsraelKnowledgeLaboratoriesMassachusettsMedical StudentsMedical centerMetabolicMethodsMolecularMolecular GeneticsMonitorNeurobiologyNew EnglandPathogenesisPatient CarePediatric HospitalsPhysiologyProductivityProteomicsPublic Health SchoolsResearchResearch InstituteResearch PersonnelResourcesScientistServicesTalentsTeaching HospitalsTrainingTransgenic AnimalsTranslational ResearchUpdateWomanclinical investigationcost effectiveenergy balanceexperiencegenetic architectureinter-institutionalmacrovascular diseasemedical schoolsmetabolomicsmultidisciplinaryoptimal treatmentsprogramsrepositorytraining opportunitytraittype I and type II diabetesweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The Boston Area Diabetes Endocrinology Research Center (BADERC) is a consortium of
laboratory-based and clinical investigators whose efforts are directed toward addressing the major
research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type
2 diabetes, and their associated microvascular and macrovascular complications. The Center
Director (Jose Florez) and Associate Directors (Barbara Kahn and Alexander Soukas) are highly
productive senior investigators of international stature. The 64 participating scientists, with
combined annual direct costs in excess of $110M in diabetes-related grant support, are based at
various Boston-area research institutions, including the major Harvard Medical School-affiliated
teaching hospitals (the Massachusetts General Hospital, the Beth Israel Deaconess Medical
Center, the Brigham and Women's Hospital, Boston Children’s Hospital) and research institutes
(the School of Public Health, Dana-Farber Cancer Institute, the Broad Institute), the Boston
University Medical Center, and the Tufts New England Medical Center. These investigators are
working at the cutting edge of fields most relevant to defining the pathogenesis and optimal
treatment of type 1 and type 2 diabetes, such as 1) the molecular basis of insulin action and
insulin resistance; 2) the neurobiology of energy balance; 3) the immunologic basis and optimal
therapies for autoimmunity and transplant rejection; 4) the genetic architecture of diabetes and
related traits; and 5) the development of new methods for glycemic monitoring and control. The
BADERC offers these scientists an Enrichment Program and an array of core support services
(Cell Biology, Transgenic Animals, Metabolic Physiology) that incorporate the latest technical
advances in molecular genetics, cell biology, and metabolic physiology provided by
acknowledged experts and provide hands-on training. New Cores in Clinical Investigation and
Bioinformatics are proposed in this application. BADERC investigators also receive facilitated
access to several platforms of the Broad Institute (Genomics, Proteomics, Metabolomics,
Imaging, Gene editing). The BADERC also offers a highly subscribed and successful Pilot &
Feasibility grant program, and BADERC investigators support summer medical students for a
research experience. The easy access to cost-effective support services of outstanding quality,
together with the educational and pilot grants program, have promoted many collaborations, and
attracted new talent from this outstanding scientific community to diabetes research. Finally, the
Center strives to foster the closest interactions between the laboratory based and clinical
scientists, so as to ensure the translation of research discoveries into advances in the care of
patients with diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin Core
-
批准号:10586201
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2023
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Autophagy and Mitochondrial Permeability in Aging and Longevity
-
批准号:10688322
-
项目类别:
-
资助金额:$34.44万
-
财政年份:2022
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10087180
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10264030
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10646433
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10432084
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Regulation of autophagy and mitochondrial permeability by target of rapamycin complex 2
-
批准号:10241881
-
项目类别:
-
资助金额:$64.91万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
-
批准号:10371988
-
项目类别:
-
资助金额:$56.44万
-
财政年份:2017
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
-
批准号:9906124
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2017
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Epigenetic regulation of metabolism by target of rapamycin complex 2
-
批准号:8926980
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2014
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Epigenetic regulation of metabolism by target of rapamycin complex 2
-
批准号:8814823
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2014
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Dissecting the molecular mechanism of metformin action
-
批准号:8617271
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2013
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Dissecting the molecular mechanism of metformin action
-
批准号:8488698
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2013
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8704232
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8281499
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8066937
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8486425
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:7869156
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.
-
批准号:7669330
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2007
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.
-
批准号:7524933
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2007
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
海外基金